Latest Announcements

Black Rose Industries Ltd reported a robust performance in Q1 FY27, with revenue and profit after tax increasing by 48% and 146%, respectively, driven by strong growth in the distribution business and improved margins across key product categories.

Exide Industries Limited has informed the Exchange about transcript of earnings call for Q1 FY 2026-27, with a strong performance in all major businesses, led by 2-wheeler and 4-wheeler OEM, home UPS, solar, and exports, resulting in a standalone revenue growth of 17.6% and EBITDA margin expansion by 20 basis points on a year-on-year basis.

C.E. Info Systems Limited has published its standalone and consolidated un-audited financial results for the quarter ended June 30, 2026, in newspapers. The results show a net profit of Rs. 6,644 lakhs for the quarter, with a total income from operations of Rs. 12,758 lakhs. The company's paid-up equity share capital remains at Rs. 1,095 lakhs, with reserves excluding revaluation reserve and debit balance of Rs. 89,400 lakhs.

The Anup Engineering Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors. The results include a profit before exceptional items and tax of ₹120.93 crore, a 2,701.61 crore profit before tax, and a tax expense of ₹41.00 crore.

Exide Industries Ltd reported a strong Q1 FY27 performance with a 17.6% standalone revenue growth, driven by double-digit growth across all major businesses, including 2-wheeler and 4-wheeler OEM, home UPS, solar, and industrial infrastructure. EBITDA stood at INR655 crores, up 19.5% year-on-year, with EBITDA margin at 12.4%. The company remains debt-free and generates healthy operating cash flows.

Samvardhana Motherson International Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a 17% growth in revenue and a 26% increase in EBITDA. The company has also announced new acquisitions and capacity expansions.

Samvardhana Motherson International Ltd reported its unaudited financial results for the quarter ended June 30, 2026, with revenue growing 17% YoY to a record high, driven by a healthy performance across its businesses. The company's profitability remained resilient despite input cost inflation and a challenging geopolitical environment. The balance sheet remains strong, with a leverage ratio of 0.8x, providing ample capacity for organic and inorganic growth.

Samvardhana Motherson International Limited (SAMIL) announced its financial results for the first quarter of fiscal year 2026-27, with the company reporting its highest-ever quarterly revenue, driven by healthy performance across its businesses. The company's leverage ratio stood at a comfortable 0.8x, providing ample capacity to pursue both organic and inorganic growth. The company also operationalised three new plants during the quarter and acquired several businesses, including Shenzhen Autocruis, Nexans Autoelectric, and Yutaka Giken.

Savita Oil Technologies Limited has announced its unaudited financial results for Q1 FY 2026-27, reporting a record quarterly performance with a 49.2% YoY growth in total income and a 434.7% YoY rise in Profit Before Tax.

Savita Oil Technologies Ltd reported a record quarterly performance with highest-ever quarterly revenue of ~Rs. 1,512 crore and Profit Before Tax of ~Rs. 386 crore, representing YoY growth of 49.2% and 434.7%, respectively.

Karnataka Bank Limited has announced its Q1 FY27 earnings, with the bank achieving its highest ever aggregate business of INR1,97,007 crores as of June 30, 2026, up by 3% Q-o-Q and 11% Y-o-Y. Gross Advances stood at INR86,610 crores, reflecting a Q-o-Q growth of 4% and a Y-o-Y growth of 17%. The bank's focus on growing retail, Agri and MSME segments has shown positive results, with the segment growing from INR51,197 crores to INR53,172 crores.

Clean Science and Technology Ltd reported its Q1 FY27 earnings, with a steady performance despite external challenges. The company achieved its highest ever consolidated sales, reaching approximately INR264 crores. The EBITDA and PAT margins are at 43% and 36%, respectively, translating into an EBITDA of INR87 crores and PAT of INR 73 crores. The company's HALS business continues to drive operating leverage and sustainable profit improvement.

Clean Science and Technology Limited reported Q1 FY27 earnings, with revenue improving by 5% to INR 203 crores, EBITDA at 43%, and PAT at 36%. The company achieved its highest ever consolidated sales of INR 264 crores, with a 7% sequential growth and a 10% Y-o-Y increase. The HALS business continues to drive operating leverage and sustainable profit improvement, with CFCL becoming operationally self-sustaining and reaching a milestone by becoming self-sustaining.

Entertainment Network (India) Ltd announced its audited financial results for Q1FY27, with consolidated revenues at ₹113 Crores, EBITDA growth of 42%, and digital business revenue growing 43% YoY.

Entertainment Network (India) Ltd has released its Q1FY27 Investors Presentation, showcasing a 42% YoY growth in EBITDA to ₹87.9 Mn and a 85.3% YoY growth in PAT to ₹17.6 Mn. The company's digital revenue grew 43.3% YoY, and its consolidated cash and cash equivalents stood at ₹4.09 Bn as of June 30, 2026.

Tilaknagar Industries Limited announces its highest-ever sales in Karnataka, with Imperial Blue recording its highest-ever sales in the state during July 2026, and the Company expanding its premiumization strategy through House of TI, the Company's luxury vertical.

Swiggy Limited has outlined its FY31 vision at Capital Markets Day 2026, setting out its goal to build a ₹10,000 Cr. Adjusted EBITDA business, more than tripling consolidated Gross Order Value (GOV) to approximately ₹2.5 Lakh Cr. from ₹67,734 Cr. in FY26.

Biocon Ltd has announced its Q1 FY27 earnings, with revenue from operations at ₹4,336 Cr, a 10% YoY growth. The company's biosimilars segment saw a 16% YoY growth, driven by the North America market, while the generics segment reported a 21% YoY growth. The company's EBITDA margin for the biosimilars segment was 25%, and 7% for the generics segment.

Biocon Limited has announced its Q1 FY27 earnings, with revenue from operations at ₹4,336 crore, a 10% YoY growth. The company's biosimilars segment saw a 16% YoY growth, driven by the North America market, while the generics segment reported a 21% YoY growth. The company has also announced the EMA approval for its second insulin drug product line in Malaysia, which is expected to support future growth.

All Time Plastics Limited has informed the Exchange about Investor Presentation for Q1FY27, highlighting resilience in business amid volatility, with revenue growth, improved capacity utilization, and strong order book.